Constantin M.
- Country
- Romania
- Department
- #3964:Cardiology
Research Overview
- Inclisiran for Prevention of Major Adverse Cardiovascular Events in High-Risk Primary Prevention Patients with Atherosclerotic Cardiovascular Disease
- Phase III Randomized Double‑Blind Trial of Elecoglipron (AZD5004) on Cardiovascular Mortality and Hospitalization in Adults with HFpEF or HFmrEF on Background Dapagliflozin
- Phase 3 Randomized Study Comparing Asundexian and Apixaban for Stroke Prevention in Atrial Fibrillation Patients at Risk
Data & Insights
Has run more than one trial at 897 of 1598 partner sites.
Specializations
Cardiovascular Disease Prevention
The investigator specializes in the prevention and treatment of atherosclerotic cardiovascular disease (ASCVD), with particular focus on innovative therapeutic approaches for high-risk patients. Their research encompasses both primary and secondary prevention strategies using novel lipid-lowering therapies.
- Primary prevention of cardiovascular events
- Lipid management strategies
- Cardiovascular risk reduction
Their work extends to investigating treatments targeting lipoprotein(a) levels in patients with established cardiovascular disease.
Heart Failure Management
The investigator conducts research in the treatment of heart failure with reduced ejection fraction (HFrEF). Their work focuses on evaluating novel therapeutic agents for improving cardiac function and patient outcomes.
- Cardiac function improvement
- Treatment tolerability assessment
- Novel therapeutic approaches
Their research aims to advance treatment options for patients with compromised cardiac function.
Atrial Fibrillation Therapeutics
The investigator focuses on developing treatments for atrial fibrillation, particularly in stroke prevention. Their research includes evaluation of novel anticoagulation approaches and alternative treatments for patients unsuitable for conventional therapy.
- Stroke prevention strategies
- Systemic embolism prevention
- Alternative anticoagulation approaches
Their work encompasses comparative studies of new anticoagulants for improved safety and efficacy profiles.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.